n-3 fatty acids and periodontitis in US adults
- PMID: 21034880
- PMCID: PMC3320731
- DOI: 10.1016/j.jada.2010.08.009
n-3 fatty acids and periodontitis in US adults
Abstract
Background: Periodontitis is a common, chronic inflammatory disease. Although n-3 fatty acids have anti-inflammatory properties, it is unclear whether n-3 fatty acids can treat or prevent periodontitis.
Method: We studied 9,182 adults aged 20 years and older who participated in the National Health and Nutrition Examination Survey between 1999 and 2004. Periodontitis was assessed by dental exam and was defined as >4 mm pocket depth and >3 mm attachment loss in any one tooth. Intake of n-3 fatty acids was assessed by 24-hour dietary recall. We used multivariable logistic regression to estimate the associations between periodontitis and intakes of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and linolenic acid (LNA).
Results: The weighted prevalence and 95% confidence interval (CI) of periodontitis was 8.2% (95% CI 7.0 to 9.4). Compared with the lowest tertiles, the adjusted odds ratios for periodontitis associated with the highest tertiles of dietary n-3 intake were 0.78 (95% CI 0.61 to 1.00; P=0.009) for DHA, 0.85 (95% CI 0.67 to 1.08; P=0.10) for EPA, and 0.86 (95% CI 0.60 to 1.23; P=0.28) for LNA. The associations were little changed by multivariable adjustment or exclusion of individuals reporting use of dietary supplements containing DHA, EPA, or LNA.
Conclusions: In this nationally representative sample, higher dietary intakes of DHA and, to a lesser degree, EPA, were associated with lower prevalence of periodontitis. Interventional studies are needed to confirm the potential protective effects of n-3 fatty acids on periodontitis.
Copyright © 2010 American Dietetic Association. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest Statement: Dr.Mukamal is the principal investigator on an ongoing study funded by Harvard Medical School for which BIDMC received a donation of docosahexaenoic acid (DHA)and placebo capsules from Martek Corporation. Drs. Phillips, Davis, and Naqvi are coinvestigators on that trial. Martek provided no other resources or funds and has no role in the conduct or analysis of that study. Martek had no role whatsoever in the current manuscript. There are no other financial or personal interests to disclose.
Catherine Buettner provided programing support and expertise navigating the NHANES database.
Russell S. Phillips provided funding, guidance on the conception of relevent outcomes to study, the secondary analysis and data interpretation.
Roger B. Davis provided statistical and programing expertise.
Kenneth J. Mukamal provided guidance on the primary analysis plan, data interpretation and preparation of the manuscript.
Figures
Comment in
-
n-3 fatty acid intake and periodontal disease.J Am Diet Assoc. 2010 Nov;110(11):1650-2. doi: 10.1016/j.jada.2010.08.017. J Am Diet Assoc. 2010. PMID: 21034877 No abstract available.
References
-
- Serhan CN, Jain A, Marleau S, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol. 2003;171:6856–65. - PubMed
-
- Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr. 2007;85:385–91. - PubMed
-
- Eberhard J, Heilmann F, Acil Y, Albers HK, Jepsen S. Local application of n-3 or n-6 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol. 2002;29:364–9. - PubMed
-
- Campan P, Planchand PO, Duran D. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol. 1997;24:907–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
